GSK’s RSV vaccine shows long-term efficacy in late-stage trial
(Reuters) -GSK on Wednesday said its vaccine for the respiratory
gsk’s
Cheap copies of GSK’s HIV prevention drug could be ready in 2026
By Natalie Grover LONDON -British drugmaker GSK has struck a